Spurred by health care reforms, Chinese medical PVC compounder expands

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: April 22, 2013 11:15 am ET
Updated: April 22, 2013 11:24 am ET

Image By: Steve Toloken Huang Yimei, vice general manage of Hopefinder Polymer & Science Technology Co. Ltd.'s Shanghai factory

Related to this story

Topics Medical, Materials, Materials Suppliers, China, Compounding

SHENZHEN, CHINA — Chinese medical-grade PVC compounder Hopefinder Polymer Science & Technology Co. Ltd. is spending at least 100 million Chinese yuan ($16.2 million) on a new factory in Jiangsu province to meet rapidly growing demand, in part from healthcare reforms in China and the country's aging population.

The first phase of its new compounding facility, in the city of Changzhou, will open late next year with 30,000 metric tons of capacity, more than double the company's current production, said Huang Yimei, vice general manager of the company's Shanghai factory, in an April 17 interview at the China Medical Equipment Fair in Shenzhen.

The second stage in Changzhou will open a year later, in 2015, and will include an additional 20,000 tonnes of capacity, she said. The company currently has 20,000 metric tons of capacity at factories in Shenzhen and Shanghai.

The total investment in Jiangsu, which will include research and development labs, will be 200 million yuan ($32.4 million), Huang said.

Right now the vast majority of the company's PVC compounds are sold to factories in China that ultimately export their products, but that's starting to change as domestic demand grows, Huang said.

In particular, foreign-owned medical device factories in China that are trying to be more competitive in the Chinese domestic market are starting to replace their imported materials with Hopefinder's grades, she said.

The company said its compounds meet international standards such as ISO 10993.

Huang said Hopefinder is benefitting from government plans to substantially boost health care spending in China, including a $125 billion plan to provide a basic level of health care to all its residents and upgrade 2,000 rural hospitals by 2020.

Longer term, the company said it expects both China's healthcare reforms and its aging society to be significant drivers of demand.

As an example, demand for vinyl tubing is rapidly growing after the Chinese government recently began reimbursing hospitals for hemodialysis procedures, said Andrew See, a consultant with Singapore-based Medipro Consultancy and Services. See, who advises Hopefinder, participated in the interview at the company's booth.

China's medical device market grew from $14 billion in 2009 to $23 billion last year, and is projected to hit $38 billion by 2015, for average annual growth of 19 percent, according to data from the China Association for Medical Device Industry presented at a conference during the CMEF trade fair, which was held from April 17 to April 20.

Company executives also said they hope to increase direct exports with the new facility.


Comments

Spurred by health care reforms, Chinese medical PVC compounder expands

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: April 22, 2013 11:15 am ET
Updated: April 22, 2013 11:24 am ET

Post Your Comments


Back to story


More stories

Image

Tessy investing $10 million in new plant, infrastructure

July 30, 2014 4:57 pm ET

Tessy Plastics Corp. continues to buy factory buildings in upstate New York — acquiring a 112,000-square-foot former Honeywell building in...    More

Image

Styrolution will open new production late 2014

July 30, 2014 12:54 pm ET

Germany-based styrenic materials group, Styrolution, has announced it is expanding its facility in Ludwigshafen, Germany.    More

Unipex Group buys Ferguson Chemical Innovation

July 29, 2014 1:57 pm ET

Chemical distributor Unipex Group Inc. announced July 29 that it had purchased Ferguson Chemical Innovation, a Brampton, Ontario-based supplier of...    More

Image

Carbon black supplier Orion begins trading on NYSE

July 29, 2014 11:29 am ET

Orion Engineered Carbons S.a.r.l. has priced the initial public offering of 19.5 million common shares at a price to the public of $18 per share.    More

Image

Dow sees solid second quarter performance

July 29, 2014 11:19 am ET

Dow Chemical Co. has reported its second quarter figures, with its seventh consecutive quarter of growth, according to the company.
More

Market Reports

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

2014 Injection Molding Industry Report

GROWTH, OPPORTUNITY IN SIGHT FOR INJECTION MOLDERS IN 2014

In the wake of the economic turbulence earlier in this decade, molders today find themselves in much better shape. Molders are gaining a competitive advantage by investing in people, equipment and seeking inroads into new markets on a global scale.

Growth in the injection molding industry is going to be driven by low financing costs and a continued move to reshore some business.

Learn more

Shale Gas Market - Analysis of North American Region

This report highlights the impact of shale-based natural gas on the North American plastics market and features an in-depth analysis of production trends in the United States during 2013 and a forecast for 2014 and beyond.

Learn more

Upcoming Plastics News Events

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events